Honestly, the SpaceX Prospectus Is Far Worse Than I Imagined

The article argues SpaceX’s expected June 12 IPO, at a proposed $1.75 trillion valuation on $18.67 billion of 2025 sales, would imply an unsustainable near-94x price-to-sales multiple. It also highlights weak xAI growth versus peers, with first-quarter revenue of $818 million up just 12.5% year over year, alongside a $4.94 billion net loss and $6.58 billion in adjusted EBITDA that the author says masks poor economics. Overall, the piece is a bearish valuation critique of SpaceX and the broader AI/space investment narrative rather than a fresh fundamental catalyst.

Analysis

The setup is less a fundamental short on a single issuer than a sentiment event that can reprice the entire private-market-to-public-market complex. A marquee IPO with a stretched multiple and heavy loss-adjusted optics creates a near-term scarcity trade in the “AI + space” basket, but the second-order loser is disciplined capital allocators: every venture-backed founder and late-stage growth board now has a fresh comp to justify pricing that public markets may not be willing to clear after lockup. That tends to compress forward IRRs for adjacent late-stage rounds, even if headline IPO demand is strong in the first few sessions.

For NDAQ, the impact is more tactical than directional. A fast-track inclusion narrative can drive index-chasing flows and temporary volume, but the bigger implication is that exchange rule changes are being stress-tested by a name with unusually high retail/CTA reflexivity. If the stock gaps, the exchange wins on fees and attention; if it rolls over, it becomes a cautionary example that could invite scrutiny of accelerated index inclusion and listing standards. That makes the risk asymmetrically reputational rather than economic.

On the AI side, the competitive read-through is actually bearish for the weakest revenue-quality names and bullish for compute winners with visible monetization. A headline valuation that implies multiple-years-ahead perfection will likely force investors to distinguish between model leaders with real enterprise pull-through and “story” companies with poor conversion of spend into revenue. That should favor NVDA and, to a lesser extent, the ecosystem of picks-and-shovels providers, while keeping pressure on TSLA’s multiple because markets will increasingly separate visionary optionality from operating execution.

The contrarian angle is timing: in the first weeks, fundamentals can matter less than float scarcity, retail momentum, and index anticipation. If the deal is well-subscribed, the better trade may be fading the euphoric phase only after the first lockup-related distribution window or when post-IPO growth deceleration becomes impossible to ignore. The bear case is not that the IPO fails on day one; it is that the market spends 1-3 months discovering that the valuation assumes a capital-light earnings machine while the business still behaves like a capital sink.

Key Decisions for Investors

• Short TSLA on rallies into the IPO window; use a 1-3 month horizon. Risk/reward improves if the market starts extrapolating the IPO multiple into Musk comps and re-rates TSLA as a lower-quality optionality asset rather than an operating growth name.
• Buy NVDA on any post-IPO AI basket weakness; 1-2 month trade. The cleaner revenue-to-infrastructure linkage should attract rotation away from speculative model builders if investors demand proof of monetization.
• Initiate a tactical long NDAQ / short high-beta IPO basket pair for 2-6 weeks. The exchange benefits from trading velocity and listing attention regardless of post-deal fundamental performance, while the basket trades on sentiment beta.
• Sell downside vol on the new issue only after first-week stabilization, not into launch. Structure as a defined-risk put spread if borrow is tight; the edge is in fading implied volatility once hype peaks, not fighting the initial squeeze.
• Avoid long exposure to late-stage private AI names until after the IPO clears and secondary comps reset. The risk is a broader markdown in venture marks over the next quarter, especially if public-market investors start applying a 30-45x sales ceiling to frontier narratives.